Convalescent plasma for covid-19–induced ARDS in mechanically ventilated patients
B Misset, M Piagnerelli, E Hoste… - … England Journal of …, 2023 - Mass Medical Soc
Background Passive immunization with plasma collected from convalescent patients has
been regularly used to treat coronavirus disease 2019 (Covid-19). Minimal data are …
been regularly used to treat coronavirus disease 2019 (Covid-19). Minimal data are …
Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month …
L Jin, R Tang, S Wu, X Guo, H Huang… - Emerging Microbes & …, 2023 - Taylor & Francis
Antibody persistence and safety up to 12 months of heterologous orally administered
adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in individuals who were …
adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in individuals who were …
Trends in Antibody Titers after SARS-CoV-2 Vaccination—Insights from Self-Paid Tests at a General Internal Medicine Clinic
H Kusunoki, K Ekawa, M Ekawa, N Kato, K Yamasaki… - Medicines, 2023 - mdpi.com
Background: The rise in antibody titers against the novel coronavirus (SARS-CoV-2) and its
duration are considered an important indicator for confirming the effect of a COVID-19 …
duration are considered an important indicator for confirming the effect of a COVID-19 …
COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician's Perspective
H Kusunoki - Pharmacoepidemiology, 2023 - mdpi.com
More than 3 years have passed since the emergence of COVID-19. On 8 May 2023, COVID-
19 in Japan was downgraded to Category 5 by the Infectious Disease Control Law. In …
19 in Japan was downgraded to Category 5 by the Infectious Disease Control Law. In …
Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare …
I Sarrigeorgiou, D Moschandreou, A Dimitriadis… - PLoS …, 2022 - journals.plos.org
Studies on the humoral response to homologous BNT162b2 mRNA-vaccination focus
mainly on IgG antibody dynamics, while long-term IgA kinetics are understudied. Herein …
mainly on IgG antibody dynamics, while long-term IgA kinetics are understudied. Herein …
Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population
The SARS CoV-2 antibody and CD4+ T cell responses induced by natural infection and/or
vaccination decline over time and cross-recognize other viral variants at different levels …
vaccination decline over time and cross-recognize other viral variants at different levels …
A Mechanical Assay for the Quantification of Anti-RBD IgG Levels in Finger-Prick Whole Blood
A large portion of the global population has been vaccinated with various vaccines or
infected with SARS-CoV-2, the virus that causes COVID-19. The resulting IgG antibodies …
infected with SARS-CoV-2, the virus that causes COVID-19. The resulting IgG antibodies …
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine …
J Serwanga, C Baine, S Mugaba, V Ankunda… - Frontiers in …, 2023 - frontiersin.org
Introduction The duration and timing of immunity conferred by COVID-19 vaccination in sub-
Saharan Africa are crucial for guiding pandemic policy interventions, but systematic data for …
Saharan Africa are crucial for guiding pandemic policy interventions, but systematic data for …
Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity
MM Dourdouna, EB Tatsi, V Syriopoulou… - … and Infectious Disease, 2023 - Elsevier
Cellular immunity after SARS-CoV-2 infection or immunization may be important for long-
lasting protection against severe COVID-19 disease. We investigated cellular immune …
lasting protection against severe COVID-19 disease. We investigated cellular immune …
Characteristics of humoral and cellular responses to coronavirus disease 2019 (COVID-19) inactivated vaccine in central China: A prospective, multicenter …
Y Yuan, J Xu, B Ma, G Chen, Z Wang, S Wang… - Frontiers in …, 2023 - frontiersin.org
Introduction In China, the long-term immunogenicity and adverse effects of inactivated
vaccines produced by different or the same manufacturer remain unclear. Therefore, the …
vaccines produced by different or the same manufacturer remain unclear. Therefore, the …